|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/13 | |
| A61K 9/48 | |||
| A61K 9/50 | |||
| A61P 21/00 |
| (11) | Patento numeris | 3215132 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15857591.0 |
| Europos patento paraiškos padavimo data | 2015-11-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/058872 |
| Data | 2015-11-03 |
| (87) | Numeris | WO 2016/073510 |
| Data | 2016-05-12 |
| (30) | Numeris | Data | Šalis |
| 201462075137 P | 2014-11-04 | US |
| (72) |
WENT, Gregory T., US
FULTZ, Timothy J., US
NGUYEN, Jack, US
CHERNOFF, David, US
|
| (73) |
Adamas Pharmaceuticals, Inc.,
1900 Powell Street, Suite 750, Emeryville, CA 94608,
US
|
| (54) | AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS |
| AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS |